Implantable Arterial Port-related Bloodstream Infection in Patients with Primary or Metastatic Hepatic Malignancies
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The incidence of implantable arterial post-related bloodstream infections (IAP-RBSI) among patients with unresectable hepatic malignancies is not well defined. We reviewed the 9-year incidence of implantable arterial post-related bloodstream infections in patients with hepatic malignancies, at a tertiary care center in Japan. The incidence was 1.9 infections per 10,000 catheter-days.
References
1.
Kuizon D, Gordon S, Dolmatch B
. Single-lumen subcutaneous ports inserted by interventional radiologists in patients undergoing chemotherapy: incidence of infection and outcome of attempted catheter salvage. Arch Intern Med. 2001; 161(3):406-10.
DOI: 10.1001/archinte.161.3.406.
View
2.
. Hepatocellular carcinoma - United States, 2001-2006. MMWR Morb Mortal Wkly Rep. 2010; 59(17):517-20.
View
3.
Alberts S, Roh M, Mahoney M, OConnell M, Nagorney D, Wagman L
. Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial,.... J Clin Oncol. 2010; 28(5):853-8.
PMC: 2834397.
DOI: 10.1200/JCO.2009.24.6728.
View
4.
Kemeny N, Huang Y, Cohen A, Shi W, Conti J, Brennan M
. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999; 341(27):2039-48.
DOI: 10.1056/NEJM199912303412702.
View
5.
Mermel L, Allon M, Bouza E, Craven D, Flynn P, OGrady N
. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 49(1):1-45.
PMC: 4039170.
DOI: 10.1086/599376.
View